Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Policy & Legislation

Friday Links

Posted on June 24, 2022July 25, 2022 by John C. Goodman
  • Researchers: Russia’s covid vaccine doesn’t work. Trial test results were fake.
  • Deborah Birx piles on to the assault on Scott Atlas. But remember (again), Atlas was right and his critics were wrong.
  • Could banning Juul be bad for our health?
  • Five numbers that describe our Covid response and why they all may be wrong.
  • Republican Study Committee calls for health policy reform:
  • The CBO has analyzed five versions of Medicare for All:
  • +

    Alcohol, Drugs, Homelessness and Crime

    Posted on June 23, 2022 by John C. Goodman

    Scott Alexander reviews Michael Shellenberger’s San Fransicko:

    putting it all together and squinting really hard, I think we can tell a story where 10-20% of the homeless are seriously psychotic, and another 20-30% have contributing mental health conditions including depression, PTSD, and others. Somewhere between 25% and 50% of the homeless have substance abuse problems, and this probably mostly overlaps with the 25% – 50% who have psych diagnoses.

    +

    Thursday Links

    Posted on June 23, 2022July 25, 2022 by John C. Goodman

    HHS says it doesn’t have time to review itself.

  • House panel attacks Scott Atlas. The problem: Atlas was right and the critics were wrong.
  • More Covid fraud: As much as 20% of funds for small business may have gone to scammers.
  • Paragon Health study: make HSAs an option in Obamacare.
  • What if the government stopped paying 80% of the premium for higher income folks? 3 million would stop buying the insurance.
    +
  • FTC to Fight Drug Rebates and Fees that Reduce Competition

    Posted on June 22, 2022June 22, 2022 by Devon Herrick

    On June 16, 2022 the U.S. Federal Trade Commission (FTC) issued a policy statement on drug rebates and fees paid by drug makers. The rebates and fee are paid to Pharmacy Benefit Managers (PBMs) sometimes in return for excluding cheaper alternatives on a drug plan formulary. The way it works is a drug maker will jack up the price of a given drug (like insulin) but give a steep discount to the PBM in return for guarantees that the plan will not include generic versions that cost far lesson the formulary.

    +
    • Previous
    • 1
    • …
    • 223
    • 224
    • 225
    • 226
    • 227
    • 228
    • 229
    • …
    • 238
    • Next

    For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

    During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

    John C. Goodman,

    Visit www.goodmaninstitute.org

    Subscribe via Email

    Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 36 other subscribers

    Popular Topics

    ©2025 The Goodman Institute Health Blog | Website by Lexicom